Clinical and experimental toxicology of organophosphates and carbamates /

Saved in:
Bibliographic Details
Corporate Authors: Elsevier Science & Technology.
Group Author: Ballantyne, Bryan.; Marrs, Timothy C.
Published: Butterworth Heinemann,
Publisher Address: Oxford ; Boston :
Publication Dates: 1992.
Literature type: eBook
Language: English
Subjects:
Online Access: http://www.sciencedirect.com/science/book/9780750602716
Carrier Form: 1 online resource (xix, 641 pages) : illustrations
Bibliography: Includes bibliographical references and index.
ISBN: 9781483193656
1483193659
Index Number: RA1242
CLC: R996
Contents: ""Front Cover""; ""Clinical and Experimental Toxicology of Organophosphates and Carbamates""; ""Copyright Page""; ""Table of Contents""; ""Foreword""; ""Preface""; ""Contributors""; ""Abbreviations used in the text""; ""PART I: BASIC SCIENCE""; ""Chapter 1. Overview of the biological and clinical aspects of organophosphates and carbamates""; ""Chemistry""; ""Nomenclature of antiChEs""; ""Ecological aspects""; ""ChEs and cholinergic function""; ""Toxicology""; ""References""; ""Chapter 2. Biochemical determination of cholinesterase activity in biological fluids and tissues""; ""Introduction""
""How to preserve sample quality""""Analytical methods""; ""References""; ""Chapter 3. Histochemical localization of cholinesterase in anticholinesterase poisoning""; ""Introduction""; ""Histochemical methods""; ""Cytochemical methods""; ""References""; ""Chapter 4. Pharmacology and toxicology of organophosphates""; ""Historical note""; ""Mechanism of action""; ""Cholinergic nerves""; ""Pharmacology""; ""Toxicology""; ""Therapeutic applications""; ""Acknowledgements""; ""References""; ""Chapter 5. Pharmacology and toxicology of carbamates""; ""Introduction""
""Pharmacological action of CB drugs""""Toxicological action of CB insecticides""; ""References""; ""Chapter 6. Structure-activity relationships and anticholinesterase activity""; ""Introduction""; ""Kinetics of AChE inhibition""; ""Structure of AChE""; ""OP compounds""; ""Carbamates""; ""References""; ""PART 2: NEUROTOXICITY""; ""Chapter 7. Neurobehavioural toxicology of anticholinesterases""; ""Introduction""; ""Influence of antiChEs on sensory function""; ""Influence of antiChEs on cognitive function""; ""Influence of antiChEs on motor function""
""Influence of antiChEs on affective function""""Discussion""; ""References""; ""Chapter 8. Central neurotoxicity and behavioural effects of anticholinesterases""; ""Introduction""; ""Cholinergic system in the CNS""; ""Biochemical effects of antiChEs on CNS""; ""Clinical and behavioural effects on CNS of antiChEs""; ""Conclusions""; ""References""; ""Chapter 9. Acute and subchronic neurotoxicity and cardiotoxicity of anticholinesterases""; ""Introduction""; ""Neurotoxicity""; ""Cardiac effects""; ""References""
""Chapter 10. Molecular events in delayed neuropathy: experimental aspects of neuropathy target esterase""""Introduction""; ""A review of statements about NTE and OPIDP""; ""Molecular events at the target""; ""A review of questions about NTE and OPIDP""; ""Other recent studies of NTE""; ""General conclusion""; ""References""; ""Chapter 11. Validation of a rodent model of organophosphorus-induced delayed neuropathy""; ""Introduction""; ""Distribution of neuropathic damage in rat OPIDN""; ""Biochemical index of rat OPIDN""; ""Manipulation of OPIDN in the rat""